Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
NCT02232191
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Asplenia
Interventions
BIOLOGICAL:
Pneumovax-23
Sponsor
University of California, Davis